In the first study to explain the failure to control certain bed bug populations, toxicologists at the University of Massachusetts Amherst and Korea’s Seoul National University show that some of these nocturnal blood suckers have developed resistance to pyrethroid insecticides, in particular deltamethrin, that attack their nervous systems.
The study by senior researcher John Clark and colleagues in the current issue of the Journal of Medical Entomology reveals that these pests have evolved to outsmart the latest generation of chemicals used to control them since DDT was banned. In providing this first look at a mechanism, the researchers summarize that diagnostic tools to detect the relevant mutation in bed bug populations have been “urgently needed for effective control and resistance management.”
Specifically, Clark and colleagues found that bed bugs in New York City have acquired mutations in their nerve cells, which blunt the neurotoxic effect of the pyrethroid toxins used against them. The mutations affect sodium channels (resembling pores) in the neurons’ outer membrane, where electrical nerve impulses are produced. In the past, these nervous system poisons could effectively paralyze and kill the bugs, but this is no longer always the case.
Resistance means mutations are acquired over time by selection with pyrethroids, so the neuronal pores no longer respond to their toxic effects. Clark and colleagues found that these pores in New York City bed bugs are now as much as 264 times more resistant to deltamethrin. This means that even if treated, New York City bed bugs go on to suck blood from unsuspecting sleepers for many more nights.
The researchers are not sure how widely this resistance has spread, that is, whether the bugs that infest hotels, apartment buildings and homes in places other than New York City have developed the same type of immunity to chemical control. But as Clark states, “This type of pyrethroid resistance is common in many pest insects and the failure of the pyrethroids to control bed bug populations across the United States and elsewhere indicates that resistance is already widespread.”
For this study, the researchers collected hard-to-control bed bugs from New York City, plus easy-to-control bed bugs from an untreated colony in Florida, Clark explains. The New York population was determined to be highly resistant (264 times more resistant) to deltamethrin compared to the Florida population by contact exposure. Further, they found that resistance was not due to the increased breakdown of deltamethrin (enzymatic metabolism) by the resistant bed bugs but appeared to be due to an insensitive nervous system.
Using molecular techniques, they sequenced genes related to the sodium ion channel’s operation in both groups and identified two mutations found only in the resistant population. Similar mutations have been found in other pyrethroid-resistant insects and are likely the cause of the resistance in bed bugs, Clark and colleagues note. This helps to narrow the focus of the next set of experiments designed to reveal more about the acquired resistance.
There are several kinds of bed bugs but the one best adapted to the human environment is known in Latin as Cimex (“a bug”) lectularius (“lying down at home”), which shows how long they’ve been with us. Bed bugs arrived here with the earliest European visitors. These nocturnal pests feed about once every five to 10 days but are not thought to spread disease. They use two tubes, one to inject an anticoagulant and mild anesthetic, the other to suck blood.
Janet Lathrop | Newswise Science News
On track to heal leukaemia
18.01.2017 | Universitätsspital Bern
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
18.01.2017 | Power and Electrical Engineering
18.01.2017 | Materials Sciences
18.01.2017 | Life Sciences